Long-term outcomes in patients with Non Small Cell Lung Cancer (NSCLC) treated by Immune Checkpoint Inhibitors (ICIs) for a minimal duration of 2 years: a cohort study in a tertiary hospital

Autor:	S Storme, L Kiakouama, M Darrason, G Devouassoux, M Duruisseaux, S Couraud
Rok vydání:	2022
Zdroj:	11.01 - Lung cancer.
DOI:	10.1183/13993003.congress-2022.603
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f9aac129109f07ddcf9cc603c0ac3a4f https://doi.org/10.1183/13993003.congress-2022.603 Zobrazit plný text záznamu